Bucking trends.
Backed by experience. 

For more than a decade, Dr. Travis Stiles has exclusively studied the mechanisms underlying regenerative failure in the CNS. His work led to the discovery of a novel therapeutic target for the promotion of neuronal tissue regeneration after CNS damage and disease. To best translate his work into viable therapies, Dr. Stiles co-founded Novoron Bioscience early in 2014 and launched Novoroo Bioscience in 2022.

Dr. Stiles earned a PhD in Biomedical Science from the University of California, San Diego (UCSD), an MA in Exercise Physiology from the University of the Pacific, and a BA in Exercise Science from Willamette University. He has been recognized as a top innovator by groups such as J&J and Biocom and has been awarded over $3 million in federal grants. In addition, Dr. Stiles has served on multiple scientific review boards for the National Institute of Health and recently completed a four-year Federal Advisory Committee appointment to the Scientific Merit Review Board subcommittee for Regenerative Medicine in the Department of Veterans Affairs.

Mr. Drummond has more than 15 years experience working in the medical research sector. Initially, he worked as a laboratory scientist at The University of Melbourne, investigating the role of post-translational modifications to myelin antigens as a potential cause of multiple sclerosis.

In 2012, Mr. Drummond co-founded MStranslate - a science communication initiative designed to provide accurate and easy to understand updates on the latest in multiple sclerosis research to the MS community. His work in this area has been recognised worldwide, also leading him to be selected as the host of the official European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS) podcast series.